SenoRx Logo
SenoRx to Present At Piper Jaffray Health Care Conference
20. November 2008 11:28 ET | SenoRx, Inc.
IRVINE, Calif., Nov. 20, 2008 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will present at the Piper Jaffray Health Care...
SenoRx Logo
SenoRx Reports Third Quarter 2008 Gross Margin Expands to 65.0 Percent From 60.1 Percent a Year Ago; Revenue Grew 26.5 Percent for the Quarter and 34.0 Percent for the First Nine Months of 2008
10. November 2008 16:35 ET | SenoRx, Inc.
IRVINE, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its third quarter ended September 30, 2008. Revenue for the quarter increased 26.5...
SenoRx Logo
SenoRx Announces Claim Construction Hearing Held in Pending Hologic V. SenoRx Litigation
16. Oktober 2008 16:02 ET | SenoRx, Inc.
ALISO VIEJO, Calif., Oct. 16, 2008 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that a Markman claim construction hearing was held on October 15, 2008 by the United States District Court...
SenoRx Logo
SenoRx Announces Third Quarter 2008 Webcast and Conference Call
09. Oktober 2008 10:00 ET | SenoRx, Inc.
IRVINE, Calif., Oct. 9, 2008 (GLOBE NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host a conference call to review its third quarter 2008 financial results on Tuesday, November 11 at...
SenoRx Logo
SenoRx Announces Three Abstracts of Clinical Findings Related to Its Contura MLB Accepted for Presentation
18. September 2008 10:00 ET | SenoRx, Inc.
IRVINE, Calif., Sept. 18, 2008 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that three abstracts summarizing clinical findings related to its Contura(tm) Multi-Lumen Balloon (MLB) Catheter...
SenoRx Logo
SenoRx to Present At UBS Global Life Sciences Conference
16. September 2008 12:00 ET | SenoRx, Inc.
IRVINE, Calif., Sept. 16, 2008 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will present at the UBS Global Life Sciences...
SenoRx Logo
SenoRx Continues International Expansion Into Five Additional Countries
25. August 2008 09:00 ET | SenoRx, Inc.
IRVINE, Calif., Aug. 25, 2008 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has further extended its international expansion into five additional countries. SenoRx will begin...
SenoRx Logo
SenoRx and Hologic Agree to Resume Proceedings in Lawsuit
22. August 2008 08:00 ET | SenoRx, Inc.
ALISO VIEJO, Calif., Aug. 22, 2008 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that Hologic and SenoRx have agreed jointly to request that the United States District Court for the...
SenoRx Logo
SenoRx Reports 37.7 Percent Growth in Second Quarter 2008 Revenue; Gross Margins Increase to 61.3 Percent From 57.0 Percent a Year Ago
11. August 2008 17:27 ET | SenoRx, Inc.
ALISO VIEJO, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its second quarter ended June 30, 2008. Revenue for the quarter increased 37.7...
SenoRx Logo
SenoRx to Present At the 28th Annual Canaccord Adams Global Growth Conference
29. Juli 2008 10:00 ET | SenoRx, Inc.
ALISO VIEJO, Calif., July 29, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will present at the 28th Annual Canaccord...